NextCure to Present at the JMP Securities Life Sciences Conference
08 juin 2022 08h00 HE
|
NextCure
BELTSVILLE, Md., June 08, 2022 (GLOBE NEWSWIRE) -- NextCure, Inc. (Nasdaq: NXTC), a clinical-stage biopharmaceutical company committed to discovering and developing novel, first-in-class...
NextCure Provides Business Update and Reports First Quarter 2022 Financial Results
05 mai 2022 16h05 HE
|
NextCure
On track to report data from all three clinical programs in the second half of 2022First quarter ending cash of $201.3 million expected to fund operations into the first quarter of 2024 ...
NextCure to Present at the BofA Securities 2022 Healthcare Conference
03 mai 2022 08h00 HE
|
NextCure
BELTSVILLE, Md., May 03, 2022 (GLOBE NEWSWIRE) -- NextCure, Inc. (Nasdaq: NXTC), a clinical-stage biopharmaceutical company committed to discovering and developing novel, first-in-class...
NextCure and the National Cancer Institute Announce Preclinical Data in Journal of Clinical Investigation
19 avr. 2022 07h30 HE
|
NextCure
BELTSVILLE, Md., April 19, 2022 (GLOBE NEWSWIRE) -- NextCure, Inc. (Nasdaq: NXTC), a clinical-stage biopharmaceutical company committed to discovering and developing novel, first-in-class...
NextCure to Present at 21st Annual Needham Virtual Healthcare Conference
05 avr. 2022 08h00 HE
|
NextCure
BELTSVILLE, Md., April 05, 2022 (GLOBE NEWSWIRE) -- NextCure, Inc. (Nasdaq: NXTC), a clinical-stage biopharmaceutical company committed to discovering and developing novel, first-in-class...
NextCure Provides Business Update and Reports Fourth Quarter and Full Year 2021 Financial Results
03 mars 2022 16h05 HE
|
NextCure
Multiple data readouts expected in 2022, including updates for all three clinical programs Ends 2021 with cash position of $219.6 million that is expected to fund operations into first quarter of...
NextCure to Present at 11th Annual SVB Leerink Global Healthcare Conference
08 févr. 2022 08h00 HE
|
NextCure
BELTSVILLE, Md., Feb. 08, 2022 (GLOBE NEWSWIRE) -- NextCure, Inc. (Nasdaq: NXTC), a clinical-stage biopharmaceutical company committed to discovering and developing novel, first-in-class...
NextCure and Collaborators Provide Data on Targets in Development at American Society of Hematology Annual Meeting
13 déc. 2021 08h05 HE
|
NextCure
BELTSVILLE, Md., Dec. 13, 2021 (GLOBE NEWSWIRE) -- NextCure, Inc. (Nasdaq: NXTC), a clinical-stage biopharmaceutical company committed to discovering and developing novel, first-in-class...
NextCure to Present at The JMP Securities Hematology and Oncology Summit
30 nov. 2021 08h00 HE
|
NextCure
BELTSVILLE, Md., Nov. 30, 2021 (GLOBE NEWSWIRE) -- NextCure, Inc. (Nasdaq: NXTC), a clinical-stage biopharmaceutical company committed to discovering and developing novel, first-in-class...
NextCure to Present at Piper Sandler 33rd Annual Virtual Healthcare Conference
22 nov. 2021 08h00 HE
|
NextCure
BELTSVILLE, Md., Nov. 22, 2021 (GLOBE NEWSWIRE) -- NextCure, Inc. (Nasdaq: NXTC), a clinical-stage biopharmaceutical company committed to discovering and developing novel, first-in-class...